These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 11940050)
1. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy? Zettinig G; Fueger BJ; Passler C; Kaserer K; Pirich C; Dudczak R; Niederle B Clin Endocrinol (Oxf); 2002 Mar; 56(3):377-82. PubMed ID: 11940050 [TBL] [Abstract][Full Text] [Related]
2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
3. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176 [TBL] [Abstract][Full Text] [Related]
4. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Haq M; Harmer C Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067 [TBL] [Abstract][Full Text] [Related]
5. Occult distant metastases of well-differentiated thyroid carcinoma. Zohar Y; Strauss M Head Neck; 1994; 16(5):438-42. PubMed ID: 7960741 [TBL] [Abstract][Full Text] [Related]
6. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830 [TBL] [Abstract][Full Text] [Related]
8. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma. Lin JD; Tsang NM; Huang MJ; Weng HF Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512 [TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883 [TBL] [Abstract][Full Text] [Related]
10. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793 [TBL] [Abstract][Full Text] [Related]
11. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area. Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341 [TBL] [Abstract][Full Text] [Related]
12. Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. O'Connell ME; Flower MA; Hinton PJ; Harmer CL; McCready VR Radiother Oncol; 1993 Jul; 28(1):16-26. PubMed ID: 8234866 [TBL] [Abstract][Full Text] [Related]
13. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma. Lin JD; Kao PF; Chao TC Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241 [TBL] [Abstract][Full Text] [Related]
14. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine? Proye CA; Dromer DH; Carnaille BM; Gontier AJ; Goropoulos A; Carpentier P; Lefebvre J; Decoulx M; Wemeau JL; Fossati P World J Surg; 1992; 16(4):640-5; discussion 645-6. PubMed ID: 1384244 [TBL] [Abstract][Full Text] [Related]
15. [The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician]. Farahati J; Mörtl M; Reiners C Zentralbl Chir; 2000; 125(10):830-4. PubMed ID: 11098578 [TBL] [Abstract][Full Text] [Related]
16. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. Pacini F; Cetani F; Miccoli P; Mancusi F; Ceccarelli C; Lippi F; Martino E; Pinchera A World J Surg; 1994; 18(4):600-4. PubMed ID: 7725751 [TBL] [Abstract][Full Text] [Related]
18. Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone. Bal CS; Padhy AK; Kumar A Nucl Med Commun; 2001 Aug; 22(8):881-7. PubMed ID: 11473207 [TBL] [Abstract][Full Text] [Related]
19. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547 [TBL] [Abstract][Full Text] [Related]
20. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy. Kalender E; Zeki Celen Y; Elboga U; Deniz Demir H; Yilmaz M Rev Esp Med Nucl Imagen Mol; 2012; 31(6):328-31. PubMed ID: 23084016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]